What is he best known for?
The fields of study he is best known for:
- Surgery
- Cancer
- Internal medicine
Andrew E. Rosenberg mostly deals with Pathology, Surgery, Soft tissue, Immunohistochemistry and Sarcoma.
His Pathology study incorporates themes from Solitary fibrous tumor, Anatomy and CD117.
The study incorporates disciplines such as Metastasis and Radiology in addition to Surgery.
Andrew E. Rosenberg has researched Soft tissue in several fields, including Myoepithelial Tumor, Hyalinizing clear cell carcinoma, Perineurium, Salivary gland and Myoepithelial cell.
His Immunohistochemistry study integrates concerns from other disciplines, such as Tumor suppressor gene, Cancer research, CDKN2A and B-cell lymphoma.
His Sarcoma research includes elements of Osteosarcoma, Angiosarcoma and General surgery.
His most cited work include:
- Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. (429 citations)
- Proton radiation therapy for chordomas and chondrosarcomas of the skull base. (390 citations)
- Chondrosarcoma of Bone: An Assessment of Outcome* (334 citations)
What are the main themes of his work throughout his whole career to date?
Pathology, Surgery, Soft tissue, Sarcoma and Radiology are his primary areas of study.
As part of his studies on Pathology, he often connects relevant areas like Anatomy.
Surgery is often connected to Biopsy in his work.
His studies link Lesion with Soft tissue.
His Sarcoma research includes themes of Chondrosarcoma, Metastasis and Chemotherapy.
His studies deal with areas such as Chordoma and Nuclear medicine as well as Radiation therapy.
He most often published in these fields:
- Pathology (46.84%)
- Surgery (25.24%)
- Soft tissue (19.66%)
What were the highlights of his more recent work (between 2013-2021)?
- Pathology (46.84%)
- Radiology (12.86%)
- Sarcoma (16.75%)
In recent papers he was focusing on the following fields of study:
His main research concerns Pathology, Radiology, Sarcoma, Surgery and Soft tissue.
His Pathology research focuses on subjects like Anatomy, which are linked to Enostosis.
Andrew E. Rosenberg combines subjects such as Differential diagnosis, Lesion and Liposarcoma with his study of Radiology.
His research integrates issues of Neoadjuvant therapy, CD99, Metastasis and Chemotherapy in his study of Sarcoma.
His research on Surgery often connects related areas such as Biopsy.
His study on Chondrosarcoma also encompasses disciplines like
- Hyaline, which have a strong connection to Synovial chondromatosis and Chondroma,
- Mutation together with Cancer research.
Between 2013 and 2021, his most popular works were:
- High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors. (88 citations)
- Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial. (83 citations)
- Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells (57 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Surgery
- Internal medicine
Andrew E. Rosenberg mainly focuses on Pathology, Sarcoma, Radiology, Cancer research and Surgery.
His Pathology study frequently intersects with other fields, such as Targeted therapy.
The concepts of his Sarcoma study are interwoven with issues in Malignancy, Conventional Osteosarcoma, Chemotherapy, CD99 and CDKN2A.
Andrew E. Rosenberg interconnects Duodenum and Abscess in the investigation of issues within Radiology.
His Cancer research research is multidisciplinary, relying on both Mutation, Chondrosarcoma and Isocitrate dehydrogenase.
His Surgery research is multidisciplinary, incorporating perspectives in Stewart–Treves syndrome and Breast cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
